Literature DB >> 12380406

Merits of DMPA relative to other reversible contraceptive methods.

Anita Nelson1.   

Abstract

Of all the highly effective methods of reversible contraception, depo-medroxyprogesterone acetate (DMPA) offers the longest contraceptive activity after a single dose of any method that does not need an invasive procedure to be reversed. This is an important clinical characteristic in the context of a general correlation between duration of action and efficacy. While coitally dependent methods of birth control are the least effective, daily oral contraceptives are potentially less reliable than longer acting hormonal delivery systems, such as weekly patches, monthly injections or monthly rings. Intrauterine devices and progestin-only implants provide the lowest overall risk of failure but require provider assistance to be reversed. DMPA, administered by injection every 13 weeks, offers a comparable level of contraceptive activity but can be reversed simply by discontinuing injections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12380406

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Dietary Intake and Weight Gain Among Adolescents on Depot Medroxyprogesterone Acetate.

Authors:  Hannah L H Lange; Martha A Belury; Michelle Secic; Alicia Thomas; Andrea E Bonny
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-05-05       Impact factor: 1.814

2.  Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.

Authors:  Andrea E Bonny; Michelle Secic; Barbara Cromer
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

3.  Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.

Authors:  Barbara A Cromer; Andrea E Bonny; Margaret Stager; Rina Lazebnik; Ellen Rome; Julie Ziegler; Kelly Camlin-Shingler; Michelle Secic
Journal:  Fertil Steril       Date:  2008-01-28       Impact factor: 7.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.